From the relentless rise of claim denials to major policy debates around prior authorization and the 340B program, the first half of 2025 has been defined by intense financial pressures on revenue cycles.
If the first half of 2025 felt like a whirlwind for your revenue cycle, you’re not alone. The healthcare landscape has been shifting quickly, with major developments in everything from the volume and complexity of claim denials to increased scrutiny over the 340B Drug Pricing Program and continued uncertainty surrounding prior authorizatio
The six-month mark is an apt time to take stock of the major trends shaping the industry. The following six stories have dominated the conversation and highlight the key challenges and strategic imperatives that will continue to define the year ahead for revenue cycle leaders.
Check out the infographic below or read more here
Luke Gale is the revenue cycle editor for HealthLeaders.
KEY TAKEAWAYS
The unrelenting rise in the volume and complexity of claim denials continues to plague revenue cycle operations, while increased scrutiny on prior authorization practices could signal impending policy changes.
With patients shouldering a growing share of financial responsibility, leaders are increasingly turning to digital tools to streamline the patient access experience, from scheduling to payments.
As payers face their own rising medical costs, providers should expect tougher contract negotiations and more aggressive utilization management.